Treatment with biologic DMARDs may not adversely affect lung nodules in rheumatoid arthritis patients

Objective: Lung nodules (LNs) impose diagnostic and therapeutic challenges in patients with rheumatoid arthritis (RA) due to unpredictable outcomes. Potential induction of nodulosis with the use of conventional synthetic DMARDs (csDMARD) and lack of knowledge regarding the effect of biologic disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Karadeniz, Hazan, Cindil, Emetullah, Babaoğlu, Hakan, Güler, Aslıhan Avanoğlu, Salman, Reyhan Bilici, Satış, Hasan, Ataş, Nuh, Göker, Berna, Haznedaroğlu, Şeminur, Öztürk, Mehmet Akif, Tufan, Abdurrahman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Research and Education Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176220/
https://www.ncbi.nlm.nih.gov/pubmed/35156617
http://dx.doi.org/10.5152/eujrheum.2022.21067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176220/
https://www.ncbi.nlm.nih.gov/pubmed/35156617
http://dx.doi.org/10.5152/eujrheum.2022.21067

Ejemplares similares